Withdrawal of inhaled steroids in children with non-cystic fibrosis bronchiectasis

Journal of Clinical Pharmacy and Therapeutics

Volumn 33, Issue 6, 2008, Pages 603-611

  Guran, T ^a,b   Ersu, R ^b   Karadag, B ^b   Karakoc, F ^b   Demirel, G Y ^c   Hekim, N ^c   Dagli, E ^b  

^a Taslibayir Sokak   (Turkey)

^b MARMARA UNIVERSITY   (Turkey)

^c Dr Pakize i Tarzi Laboratuarlari Turkey   (Turkey)

Author keywords

Apoptosis; Bronchial hyperreactivity; Bronchiectasis; Children; Induced sputum; Interleukin 8; Tumour necrosis factor

Indexed keywords

BUDESONIDE; FLUTICASONE PROPIONATE; INTERLEUKIN 8; STEROID; TUMOR NECROSIS FACTOR ALPHA;

ABSENCE OF SIDE EFFECTS; ADOLESCENT; APOPTOSIS; ARTICLE; BRONCHIECTASIS; BRONCHUS HYPERREACTIVITY; CLINICAL ARTICLE; DISEASE MARKER; DRUG WITHDRAWAL; FEMALE; FOLLOW UP; FORCED EXPIRATORY VOLUME; HUMAN; INFLAMMATION; LUNG FUNCTION TEST; MALE; METHACHOLINE CHALLENGE TEST; NEUTROPHIL; OXYGEN SATURATION; SCHOOL CHILD; SPUTUM; SYMPTOMATOLOGY;

ADMINISTRATION, INHALATION; ADOLESCENT; APOPTOSIS; BIOLOGICAL MARKERS; BRONCHIAL HYPERREACTIVITY; BRONCHIECTASIS; CHILD; FEMALE; GLUCOCORTICOIDS; HUMANS; INFLAMMATION; MALE; METHACHOLINE CHLORIDE; NEUTROPHILS; SPUTUM; SUBSTANCE WITHDRAWAL SYNDROME;

EID: 55949121601     PISSN: 02694727     EISSN: 13652710     Source Type: Journal    
DOI: 10.1111/j.1365-2710.2008.00951.x     Document Type: Article

References (48)

1. Angrill J, Agusti C, De Celis R et al. (2001) Bronchial inflammation and colonization in patients with clinically stable bronchiectasis. American Journal of Respiratory and Critical Care Medicine, 164, 1628 1632.
2. Anticevich SZ, Hughes JM, Black JL et al. (1996) Induction of hyperresponsiveness in human airway tissue by neutrophils - mechanism of action. Clinical and Experimental Allergy, 26, 549 556.
3. Ip M, Lam WK, So SY et al. (1991) Analysis of factors associated with bronchial hyperreactivity to metacholine in bronchiectasis. Lung, 169, 43 51.
4. Ohta K, Yamashita N (1999) Apoptosis of eosinophils and lymphocytes in allergic inflammation. Journal of Allergy and Clinical Immunology, 104, 14 21.
5. Guran T, Ersu R, Karadag B, Nuri Akpinar I, Yanikkaya Demirel G, Hekim N, Dagli E (2007) Association between inflammatory markers in induced sputum and clinical characteristics in children with non-cystic fibrosis bronchiectasis. Pediatric Pulmonology, 42, 362 369.
6. Tsang KW, Ho PL, Lam WK et al. (1998) Inhaled fluticasone reduces sputum inflammatory indices in severe bronchiectasis. American Journal of Respiratory and Critical Care Medicine, 158, 723 727.
7. Loukides S, Bouros D, Papatheodorou G et al. (2002) Exhaled H(2)O(2) in steady-state bronchiectasis: relationship with cellular composition in induced sputum, spirometry, and extent and severity of disease. Chest, 121, 81 87.
8. Ferris BG (1978) Epidemiology standardization project. The American Review of Respiratory Disease, 118, 1 120.
9. Sherman CB, Xu X, Speizer FE et al. (1992) Longitudinal lung function decline in subjects with respiratory symptoms. The American Review of Respiratory Disease, 146, 855 859.
10. Stockley RA, Bayley D, Hill SL et al. (2001) Assessment of airway neutrophils by sputum colour: correlation with airways inflammation. Thorax, 56, 366 372.
11. Polgar G, Promadhat V (1971) Pulmonary function testing in children: techniques and standards. Philadelphia, PA : WB Saunders, 87 212.
12. American Thoracic Society (1995) Standardization of spirometry, 1994 update. American Journal of Respiratory and Critical Care Medicine, 152, 1107 1136.
13. Wong HH, Fahy JV (1997) Safety of one method of sputum induction in asthmatic subjects. American Journal of Respiratory and Critical Care Medicine, 156, 299 303.
14. Watt AP, Brown V, Courtney J et al. (2004) Neutrophil apoptosis, proinflammatory mediators and cell counts in bronchiectasis. Thorax, 59, 231 236.
15. Crapo RO, Casaburi R, Coates AL et al. (2000) Guidelines for metacholine and exercise challenge testing-1999. This official statement of the American Thoracic Society was adopted by the ATS Board of Directors, July 1999. American Journal of Respiratory and Critical Care Medicine, 161, 309 329.
16. Sterk PJ, Fabbri LM, Quanjer PH et al. (1993) Airway responsiveness. Standardized challenge testing with pharmacological, physical and sensitizing stimuli in adults. Report Working Party Standardization of Lung Function Tests, European Community for Steel and Coal. Official Statement of the European Respiratory Society. European Respiratory Journal, Supplement, 16, 53 83.
17. Hargreave FE, Ryan G, Thomson NC et al. (1981) Bronchial responsiveness to histamine or metacholine in asthma: measurement and clinical significance. Journal of Allergy and Clinical Immunology, 68, 347 355.
18. Li AM, Sonnappa S, Lex C et al. (2005) Non-CF bronchiectasis: does knowing the aetiology lead to changes in management? European Respiratory Journal, 26, 8 14.
19. Eller J, Lapa e Silva JR, Poulter LW, Lode H, Cole PJ (1994) Cells and cytokines in chronic bronchial infection. Ann N Y Acad Sci, 725, 331 345.
20. Martinez-Garcia MA, Perpina-Tordera M, Roman-Sanchez P et al. (2006) Inhaled steroids improve quality of life in patients with steady-state bronchiectasis. Respiratory Medicine, 100, 1623 1632.
21. Tsang KW, Tan KC, Ho PL et al. (2005) Inhaled fluticasone in bronchiectasis: a 12 month study. Thorax, 60, 239 243.
22. Visser MJ, Brand PL, Boezen HM et al. (2002) Clinical and immunologic factors associated with the presence or absence of airways hyper-responsiveness in childhood asthma. Clinical and Experimental Allergy, 32, 1278 1284.
23. Dahl R, Larsen BB, Venge P (2002) Effect of long-term treatment with inhaled budesonide or theophylline on lung function, airway reactivity and asthma symptoms. Respiratory Medicine, 96, 432 438.
24. Kao CC, Huang JL, Ou LS et al. (2005) The prevalence, severity and seasonal variations of asthma, rhinitis and eczema in Taiwanese schoolchildren. Pediatric Allergy and Immunology, 16, 408 415.
25. Bahous J, Cartier A, Pineau L et al. (1984) Pulmonary function tests and airway responsiveness to methacholine in chronic bronchiectasis of the adult. Bulletin Européen de Physiopathologie Respiratoire, 20, 375 380.
26. Varpela E, Laitinen LA, Keskinen H et al. (1978) Asthma, allergy and bronchial hyper-reactivity to histamine in patients with bronchiectasis. Clinical Allergy, 8, 273 280.
27. Pang J, Chan HS, Sung JY (1989) Prevalence of asthma, atopy, and bronchial hyperreactivity in bronchiectasis: a controlled study. Thorax, 44, 948 951.
28. Juniper EF, Frith PA, Hargreave FE (1981) Airway responsiveness to histamine and metacholine: relationship to minimum treatment to control symptoms of asthma. Thorax, 36, 575 579.
29. Eggleston PA, Rosenstein BJ, Stackhouse CM et al. (1988) Airway hyperreactivity in cystic fibrosis. Clinical correlates and possible effects on the course of the disease. Chest, 94, 360 365.
30. Kerstjens HA, Brand PL, Postma DS (1996) Risk factors for accelerated decline among patients with chronic obstructive pulmonary disease. American Journal of Respiratory and Critical Care Medicine, 154 (6 Pt 2 S266 S272.
31. Riess A, Wiggs B, Verburgt L et al. (1996) Morphologic determinants of airway responsiveness in chronic smokers. American Journal of Respiratory and Critical Care Medicine, 154, 1444 1449.
32. van Haren EH, Lammers JW, Festen J et al. (1995) The effects of the inhaled corticosteroid budesonide on lung function and bronchial hyperresponsiveness in adult patients with cystic fibrosis. Respiratory Medicine, 89, 209 214.
33. Verhoeven GT, Hegmans JP, Mulder PG et al. (2002) Effects of fluticasone propionate in COPD patients with bronchial hyperresponsiveness. Thorax, 57, 694 700.
34. Zhang X, Moilanen E, Kankaanranta H (2001) Beclomethasone, budesonide and fluticasone propionate inhibit human neutrophil apoptosis. European Journal of Pharmacology, 431, 365 371.
35. Sepper R, Konttinen YT, Ding Y et al. (1995) Human neutrophil collagenase (MMP-8), identified in bronchiectasis BAL fluid, correlates with severity of disease. Chest, 107, 1641 1647.
36. Hamutcu R, Rowland JM, Horn MV et al. (2002) Clinical findings and lung pathology in children with cystic fibrosis. American Journal of Respiratory and Critical Care Medicine, 165, 1172 1175.
37. Hoshino M, Nakamura Y (1996) Anti-inflammatory effects of inhaled beclomethasone dipropionate in nonatopic asthmatics. European Respiratory Journal, 9, 696 702.
38. Inoue H, Aizawa H, Fukuyama S et al. (1999) Effect of inhaled glucocorticoid on the cellular profile and cytokine levels in induced sputum from asthmatic patients. Lung, 177, 53 62.
39. Keatings VM, Jatakanon A, Worsdell YM et al. (1997) Effects of inhaled and oral glucocorticoids on inflammatory indices in asthma and COPD. American Journal of Respiratory and Critical Care Medicine, 155, 542 548.
40. Zhang X, Moilanen E, Adcock IM et al. (2002) Divergent effect of mometasone on human eosinophil and neutrophil apoptosis. Life Sciences, 71, 1523 1534.
41. Kato T, Takeda Y, Nakada T et al. (1995) Inhibition by dexamethasone of human neutrophil apoptosis in vitro. Natural Immunity, 14, 198 208.
42. Liles WC, Dale DC, Klebanoff SJ (1995) Glucocorticoids inhibit apoptosis of human neutrophils. Blood, 86, 3181 3188.
43. Meagher LC, Cousin JM, Seckl JR et al. (1996) Opposing effects of glucocorticoids on the rate of apoptosis in neutrophilic and eosinophilic granulocytes. Journal of Immunology, 156, 4422 4428.
44. Whyte M, Renshaw S, Lawson R et al. (1999) Apoptosis and the regulation of neutrophil lifespan. Biochemical Society Transactions, 27, 802 807.
45. Haslett C (1999) Granulocyte apoptosis and its role in the resolution and control of lung inflammation. American Journal of Respiratory and Critical Care Medicine, 160 (5 Pt 2 S5 S11.
46. Tsang KW, Lam WK, Sun J et al. (2002) Regression of bilateral bronchiectasis with inhaled steroid therapy. Respirology, 7, 77 81.
47. John M, Au BT, Jose PJ, Lim S et al. (1998) Expression and release of interleukin-8 by human airway smooth muscle cells: inhibition by Th-2 cytokines and corticosteroids. American Journal of Respiratory Cell and Molecular Biology, 18, 84 90.
48. Gaga M, Bentley AM, Humbert M et al. (1998) Increases in CD4+ T lymphocytes, macrophages, neutrophils and interleukin 8 positive cells in the airways of patients with bronchiectasis. Thorax, 53, 685 691.